Janux Therapeutics Inc

NASDAQ:JANX   3:06:49 PM EDT
11.43
+0.43 (+3.91%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)475.83M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.85 Million
Adjusted EPS-$0.34
See more estimates
10-Day MA$10.93
50-Day MA$12.71
200-Day MA$19.02
See more pivots

Janux Therapeutics Inc Stock, NASDAQ:JANX

11099 North Torrey Pines Park, Suite 290, La Jolla, California 92037
United States of America
Phone: +1.858.750.4700
Number of Employees: 33

Description

Janux Therapeutics, Inc. operates preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded in June 2017 and is headquartered in La Jolla, CA.